Emerging anticoagulant drugs

被引：19
|
作者：
Bates, SM
Weitz, JI
机构：
[1] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 09期
关键词：
anticoagulant; antithrombotic; venous thromboembolism; arterial thromboembolism; direct thrombin inhibitor;
D O I：
10.1161/01.ATV.0000084827.77945.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
引用
收藏
页码：1491 / 1500
页数：10
相关论文
共 50 条
  • [41] Drug Utilization Analysis of Anticoagulant and Antiplatelet Drugs in Cardiology Department of a Tertiary Care Hospital
    Vyas, Sonal
    Dagar, Wandeep
    Dhanawat, Meenakshi
    Manzoor, Sajaad
    Gupta, Sumeet
    Das, Rina
    Mehta, Dinesh Kumar
    JOURNAL OF YOUNG PHARMACISTS, 2022, 14 (01) : 122 - 125
  • [42] Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
    Foley, James
    Kirchhof, Paulus
    Lip, Gregory Y. H.
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (03) : 373 - 383
  • [43] A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs
    Taylor, Kellie
    Filgate, Rhys
    Guo, Ding Yu
    Macneil, Finlay
    BJU INTERNATIONAL, 2011, 108 : 45 - 50
  • [44] The Perioperative Management of Antiplatelet and Anticoagulant Drugs in Hip Fractures: Do the Surgery as Early as Possible
    Ghasemi, Mohammad Ali
    Ghadimi, Ehsan
    Shamabadi, Ahmad
    Mortazavi, S. M. Javad
    ARCHIVES OF BONE AND JOINT SURGERY-ABJS, 2022, 10 (06): : 490 - 500
  • [45] Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients
    Rossio, Raffaella
    Mandelli, Sara
    Ardoino, Ilaria
    Nobili, Alessandro
    Peyvandi, Flora
    Mannucci, Pier Mannuccio
    Franchi, Carlotta
    INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (01) : 97 - 104
  • [46] Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action
    Kollias, Anastasios
    Kyriakoulis, Konstantinos G.
    Dimakakos, Evangelos
    Poulakou, Garyphallia
    Stergiou, George S.
    Syrigos, Konstantinos
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) : 846 - 847
  • [47] Emerging Sulfated Flavonoids and Other Polyphenols as Drugs: Nature as an Inspiration
    Correia-da-Silva, Marta
    Sousa, Emilia
    Pinto, Madalena M. M.
    MEDICINAL RESEARCH REVIEWS, 2014, 34 (02) : 223 - 279
  • [48] A novel rationale for targeting FXI: Insights from the hemostatic microRNA targetome for emerging anticoagulant strategies
    Nourse, Jamie
    Danckwardt, Sven
    PHARMACOLOGY & THERAPEUTICS, 2021, 218
  • [49] In vivo Anticoagulant Activity of Immediate Release Tablets of Dabigatran Etexilate Mesylate Cocrystals
    Gawade, Ashwini
    Boldhane, Sanjay
    Pawar, Anil
    Pujari, Rohini
    Kuchekar, Ashwin
    ADVANCES IN PHARMACOLOGY AND PHARMACY, 2022, 10 (01) : 1 - 7
  • [50] Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
    Di Giacomo, T. B.
    Hussein, T. P.
    Souza, D. G.
    Criado, P. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (11) : 1340 - 1346
12345